NephMadness 2015: Onconephrology • Second Round Results
Nephron Sparing Surgery vs Tyrosine Kinase Inhibitor Toxicity Winner: Tyrosine Kinase Inhibitor Toxicity 4-3 split In another narrow victory, Team Tyrosine Kinase moves to [...]
The development of malignancy after a successful kidney transplant poses unique challenges. The most common malignancies after kidney transplantation are skin cancers. Hematologic cancers are usually post transplant lymphoproliferative disorders (PTLD). Although studies have shown that certain cancers are more likely to occur in patients with CKD or with ESRD, the overall incidence of cancer clearly increases further after kidney transplantation.
Copyright © 2023 Powered by WordPress.com.